Cellectar Biosciences, Inc. (CLRB)
1.01
-0.13
(-11.40%)
USD |
NASDAQ |
Nov 16, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
Cellectar Biosciences Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2011 | 73.49% |
| December 31, 2010 | 71.08% |
| September 30, 2010 | 69.88% |
| June 30, 2010 | 63.86% |
| March 31, 2010 | 0.00% |
| December 31, 2009 | 48.70% |
| September 30, 2009 | 49.64% |
| June 30, 2009 | 71.21% |
| March 31, 2009 | 79.68% |
| December 31, 2008 | 0.00% |
| September 30, 2008 | 88.17% |
| June 30, 2008 | 90.59% |
| Date | Value |
|---|---|
| March 31, 2008 | 57.83% |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | |
| March 31, 2006 | |
| December 31, 2005 | |
| September 30, 2005 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Legend Biotech Corp. | 55.88% |
| ACADIA Pharmaceuticals, Inc. | 89.75% |
| Alnylam Pharmaceuticals, Inc. | 75.19% |
| Anika Therapeutics, Inc. | 61.57% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -169.4% |
| Return on Assets | -120.7% |
| Return on Invested Capital | -158.2% |
| Return on Net Operating Assets | -1.82K% |